CULLINAN ONCOLOGY INC filings

SEC filings by CULLINAN ONCOLOGY INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-14BIOTECHNOLOGY VALUE FUND L PCullinan Oncology, Inc.2,870,4276.5%EDGAR
SC 13G/A2024-02-14Jovan-Embiricos MoranaCullinan Oncology, Inc.468,6961.1%EDGAR
SC 13G2024-02-14Blue Owl Capital Holdings LPCullinan Oncology, Inc.3,419,8428.0%EDGAR
SC 13G/A2024-02-13VANGUARD GROUP INCCullinan Oncology, Inc.1,771,4434.1%EDGAR
SC 13G2024-02-06FRANKLIN RESOURCES INCCullinan Oncology, Inc.3,281,2807.7%EDGAR
SC 13G2024-01-29BlackRock Inc.Cullinan Oncology, Inc.2,462,2745.8%EDGAR
SC 13G/A2023-09-07BlackRock Inc.Cullinan Oncology, Inc.2,036,6514.8%EDGAR
SC 13G/A2023-02-15Jovan-Embiricos MoranaCullinan Oncology, Inc.1,577,4403.4%EDGAR
SC 13G/A2023-02-14BIOTECHNOLOGY VALUE FUND L PCullinan Oncology, Inc.4,058,8548.9%EDGAR
SC 13G/A2023-02-13CHI Advisors LLCCullinan Oncology, Inc.3,317,5447.2%EDGAR
SC 13G/A2023-02-09VANGUARD GROUP INCCullinan Oncology, Inc.2,812,9656.2%EDGAR
SC 13G2023-02-03BlackRock Inc.Cullinan Oncology, Inc.2,506,2155.5%EDGAR
SC 13G/A2022-02-14BIOTECHNOLOGY VALUE FUND L PCullinan Oncology, Inc.2,790,0186.4%EDGAR
SC 13G/A2022-02-11Foresite Capital Fund V, L.P.Cullinan Oncology, Inc.1,143,0062.6%EDGAR
SC 13G2022-02-11CHI Advisors LLCCullinan Oncology, Inc.2,476,7205.7%EDGAR
SC 13G2022-02-10Jovan-Embiricos MoranaCullinan Oncology, Inc.2,101,1534.8%EDGAR
SC 13G2022-02-09VANGUARD GROUP INCCullinan Oncology, Inc.2,366,8085.4%EDGAR
SC 13G/A2021-12-20BIOTECHNOLOGY VALUE FUND L PCullinan Oncology, Inc.2,255,3245.2%EDGAR
SC 13G2021-11-08BIOTECHNOLOGY VALUE FUND L PCullinan Oncology, Inc.1,391,9783.2%EDGAR
SC 13D2021-01-19UBS Oncology Impact Fund L.P.Cullinan Management, Inc.7,913,88718.3%EDGAR